✦ LIBER ✦

2-({6-[(3R)-3-amino-3-methylpiperidine-1-yl]-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5H-pyrrolo[3,2-d]pyrimidine-5-yl}methyl)-4-fluorobenzonitrile (DSR-12727): A potent, orally active dipeptidyl peptidase IV inhibitor without mechanism-based inactivation of CYP3A

✍ Scribed by Yukihiro Nishio; Hidenori Kimura; Naoyuki Sawada; Eiji Sugaru; Masakuni Horiguchi; Michiko Ono; Yudai Furuta; Mutsuko Sakai; Yumi Masui; Misato Otani; Takahiko Hashizuka; Yayoi Honda; Jiro Deguchi; Tsutomu Nakagawa; Hiroyuki Nakahira

Book ID: 113495395
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 509 KB
Volume: 19
Category: Article
ISSN: 0968-0896
DOI: 10.1016/j.bmc.2011.07.042

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-

(2 R )-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3- a ]pyrazin- 7(8 H )-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Kim, Dooseop; Wang, Liping; Beconi, Maria; Eiermann, George J.; Fisher, Michael 📂 Article 📅 2005 🏛 American Chemical Society 🌐 English ⚖ 327 KB

(2 S ,3 S )-3-Amino-4-(3,3-difluoropyrro

(2 S ,3 S )-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)- N,N -dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5- a ]- pyridin-6-ylphenyl)butanamide: A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

✍ Edmondson, Scott D.; Mastracchio, Anthony; Mathvink, Robert J.; He, Jiafang; Har 📂 Article 📅 2006 🏛 American Chemical Society 🌐 English ⚖ 355 KB

5-Lipoxygenase-activating protein inhibi

5-Lipoxygenase-activating protein inhibitors. Part 3: 3-{3-tert-Butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methyl-pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM643)—A potent FLAP inhibitor suitable for topical administration

✍ Nicholas Stock; Christopher Baccei; Gretchen Bain; Charles Chapman; Lucia Correa 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 343 KB

AM643 (compound 6, 3-{3-tert-butylsulfanyl-1-[4-(5-methoxy-pyrimidin-2-yl)-benzyl]-5-(5-methylpyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid) was identified as a potential candidate for formulation as a topical agent for the treatment of skin disorders involving leukotriene producti

5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole an

5-(2-Amino-pyrimidin-4-yl)-1H-pyrrole and 2-(2-amino-pyrimidin-4-yl)-1,5,6,7-tetrahydro-pyrrolo[3,2-c]pyridin-4-one derivatives as new classes of selective and orally available Polo-like kinase 1 inhibitors

✍ Michele Caruso; Barbara Valsasina; Dario Ballinari; Jay Bertrand; Maria Gabriell 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 652 KB

Synthesis of [3H]-labelled 4-[Ethyl[2,5,

Synthesis of [3H]-labelled 4-[Ethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[3H]-butan-1-ol: a high affinity radioligand for the corticotropin-releasing hormone type 1 receptor

✍ Anne-Cécile Hiebel; John S. Partilla; Richard B. Rothman; Arthur E. Jacobson; Ke 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 117 KB

3 H]-Labelled 4- [ethyl[2,5,6-trimethyl-7-(2,4,6-trimethylphenyl)pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3-[ 3 H]-butan-1-ol (3b) was prepared as a novel non-peptidic radiolabelled high affinity antagonist of the corticotropin-releasing hormone type 1 receptor (CRHR 1 ) that could be useful as a more

E3024, 3-but-2-ynyl-5-methyl-2-piperazin

E3024, 3-but-2-ynyl-5-methyl-2-piperazin-1-yl-3,5-dihydro-4H-imidazo[4,5-d]pyridazin-4-one tosylate, is a novel, selective and competitive dipeptidyl peptidase-IV inhibitor

✍ Nobuyuki Yasuda; Tadashi Nagakura; Takashi Inoue; Kazuto Yamazaki; Naruo Katsuta 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 311 KB